BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19840315)

  • 1. A unique case of nephrogenic systemic fibrosis from gadolinium exposure in a patient with normal eGFR.
    Lohani S; Golenbiewski J; Swami A; Halalau A
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29025775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of nephrogenic systemic fibrosis and calciphylaxis in a gadolinium-naïve, chronic haemodialysis patient.
    Adam MS; Jmor S; Elsayed A; Naz N
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis: fibrotic plaques and contracture following exposure to gadolinium-based contrast media.
    He A; Kwatra SG; Zampella JG; Loss MJ
    BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27073153
    [No Abstract]   [Full Text] [Related]  

  • 4. Responses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects.
    DaSilva M; O'Brien Deming M; Fligiel SE; Dame MK; Johnson KJ; Swartz RD; Varani J
    Invest Radiol; 2010 Nov; 45(11):733-9. PubMed ID: 20661146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic systemic fibrosis-related pulmonary restriction: An under-appreciated manifestation potentially reversible with imatinib therapy.
    Mansour J; Coleman C; Mendoza F; Lammi M; Saketkoo LA
    J Scleroderma Relat Disord; 2022 Oct; 7(3):NP7-NP11. PubMed ID: 36211205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alone on a collagen island: Unique findings of osseous sclerotic bodies in nephrogenic systemic fibrosis.
    Gordon ER; Trager MH; Adeuyan O; Schreidah CM; Fahmy LM; Lapolla BA; Husain S; Coromilas AJ; Geskin LJ
    JAAD Case Rep; 2023 Oct; 40():117-119. PubMed ID: 37766735
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice.
    Bhargava R; Hahn G; Hirsch W; Kim MJ; Mentzel HJ; Olsen OE; Stokland E; Triulzi F; Vazquez E
    Magn Reson Insights; 2013; 6():95-111. PubMed ID: 25114547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of gadobutrol-enhanced MRI in patients aged under 2 years-a single-center, observational study.
    Bhargava R; Noga M
    Magn Reson Insights; 2013; 6():1-12. PubMed ID: 25114540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.
    Nardone B; Saddleton E; Laumann AE; Edwards BJ; Raisch DW; McKoy JM; Belknap SM; Bull C; Haryani A; Cowper SE; Abu-Alfa AK; Miller FH; Godinez-Puig V; Dharnidharka VR; West DP
    Pediatr Radiol; 2014 Feb; 44(2):173-80. PubMed ID: 24057195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance.
    Reiter T; Ritter O; Prince MR; Nordbeck P; Wanner C; Nagel E; Bauer WR
    J Cardiovasc Magn Reson; 2012 May; 14(1):31. PubMed ID: 22607376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases.
    Zou Z; Ma L
    Indian J Dermatol; 2011 Jan; 56(1):65-73. PubMed ID: 21572796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD; Bernheisel CR
    Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation.
    Edgar E; Woltjer R; Whitham R; Gultekin SH; Watnick S; Cupler EJ
    Neuromuscul Disord; 2010 Jun; 20(6):411-3. PubMed ID: 20462761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nephrogenic systemic fibrosis and use of MR contrast media].
    Christiansen RE; Sviland L; Sekse I; Svarstad E
    Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrogenic systemic fibrosis.
    Weinreb JC; Kuo PH
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
    Foss C; Smith JK; Ortiz L; Hanevold C; Davis L
    Pediatr Dermatol; 2009; 26(5):579-82. PubMed ID: 19840315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS; Sanyal S; Abraham JL
    J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.